Copyright
©The Author(s) 2022.
World J Gastrointest Oncol. Apr 15, 2022; 14(4): 897-919
Published online Apr 15, 2022. doi: 10.4251/wjgo.v14.i4.897
Published online Apr 15, 2022. doi: 10.4251/wjgo.v14.i4.897
Figure 3 Survival curve analyses based on the systemic immune-inflammation index and platelet-lymphocyte ratio.
A-D: Survival curves of patients with the expansive growth type based on the systemic immune-inflammation index in all stages, stage Ⅰ, stage Ⅱ, and stage Ⅲ; E–H: Survival curves of patients with the intermediate type based on the platelet-lymphocyte ratio (PLR) in all stages, stage Ⅰ, stage Ⅱ, and stage Ⅲ; I–L: Survival curves of patients with the infiltrative growth type based on the PLR in all stages, stage Ⅰ, stage Ⅱ, and stage Ⅲ. INFa: The expansive growth type; INFb: The intermediate type; INFc: The infiltrative growth type; PLR: Platelet-lymphocyte ratio; SII: Systemic immune-inflammation index.
- Citation: Wang YF, Yin X, Fang TY, Wang YM, Zhang L, Zhang XH, Zhang DX, Zhang Y, Wang XB, Wang H, Xue YW. Prognostic significance of serum inflammation indices for different tumor infiltrative pattern types of gastric cancer. World J Gastrointest Oncol 2022; 14(4): 897-919
- URL: https://www.wjgnet.com/1948-5204/full/v14/i4/897.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v14.i4.897